Monocyclic L-nucleosides, analogs and uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 3, 2003
Grant Date -
Jul 18, 2002
app pub date -
Dec 31, 2001
filing date -
Oct 16, 1996
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Novel monocyclic L-Nucleoside compounds have the general formula ##STR1## Embodiments of these compounds are contemplated to be useful in treating a wide variety of diseases including infections, infestations, neoplasms, and autoimmune diseases. Viewed in terms of mechanism, embodiments of the novel compounds show immunomodulatory activity, and are expected to be useful in modulating the cytokine pattern, including modulation of Th1 and Th2 response.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully